Skip to content

Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA

Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03662607
Acronym
VR-THEIA
Enrollment
180
Registered
2018-09-07
Start date
2017-04-18
Completion date
2025-12-31
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preprocedure Anxiety

Keywords

preprocedure, anxiety, cardiac catheterization

Brief summary

The primary aim of this study is to test the hypothesis that use of VR combined with standard procedural education will result in less pre-procedural anxiety than standard procedural education alone among patients undergoing first-time cardiac catheterization. The VR technology being evaluated in this study will allow patients to experience a 3-D simulation of certain aspects of their upcoming procedure prior to the actual procedure date.

Interventions

* Baseline wellness self-assessment administered (reporting on absence or presence and degree of severity of headache, nausea, dizziness, fatigue and vision abnormalities) * Seated comfortably and free of direct obstruction * Shown individual components of the VR system (View-Master with smartphone; headphones); given instructions; encouraged to ask questions. * Begin the VR experience. Study personnel stay in the room \& provide guidance and answer questions regarding the technology * When VR experience concluded, wellness self-assessment will be administered again.

Sponsors

Corewell Health West
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled to undergo a left-heart catheterization procedure at the Meijer Heart Center * 18-75 years of age * Signed study consent form

Exclusion criteria

* History of cardiac procedure(s) in a cardiac catheterization laboratory * History of seizures, migraine headaches or severe susceptibility to motion sickness * Currently taking psychotropic drugs or on long-term psychotropic treatment * Unable to read and speak English * Visually impaired * Unable to provide written consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Anxiety Measured by the Sate-Trait Anxiety Inventory (STAI)Change from baseline visit to procedure day. Baseline visits will occur up to 4 weeks prior to procedure.The primary outcome of this study is patient anxiety, as measured by the State Trait Anxiety Inventory (STAI) score. STAI is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety - state anxiety and trait anxiety. Scores range from 20 to 80, with higher scores correlating with greater anxiety.

Countries

United States

Participant flow

Participants by arm

ArmCount
Control
Standard preprocedural education
91
VR Group (Treatment)
Standard preprocedural education plus viewing of virtual reality video
89
Total180

Baseline characteristics

CharacteristicVR Group (Treatment)TotalControl
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
47 Participants92 Participants45 Participants
Age, Categorical
Between 18 and 65 years
42 Participants88 Participants46 Participants
Age, Continuous64 years
STANDARD_DEVIATION 8
64 years
STANDARD_DEVIATION 8
64 years
STANDARD_DEVIATION 8.52
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
89 Participants180 Participants91 Participants
Sex: Female, Male
Female
35 Participants65 Participants30 Participants
Sex: Female, Male
Male
54 Participants115 Participants61 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 910 / 89
other
Total, other adverse events
0 / 910 / 89
serious
Total, serious adverse events
0 / 910 / 89

Outcome results

Primary

Change in Anxiety Measured by the Sate-Trait Anxiety Inventory (STAI)

The primary outcome of this study is patient anxiety, as measured by the State Trait Anxiety Inventory (STAI) score. STAI is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety - state anxiety and trait anxiety. Scores range from 20 to 80, with higher scores correlating with greater anxiety.

Time frame: Change from baseline visit to procedure day. Baseline visits will occur up to 4 weeks prior to procedure.

ArmMeasureValue (MEAN)Dispersion
ControlChange in Anxiety Measured by the Sate-Trait Anxiety Inventory (STAI)69.81 Mean STAI scoreStandard Deviation 17.11
VR Group (Treatment)Change in Anxiety Measured by the Sate-Trait Anxiety Inventory (STAI)65.71 Mean STAI scoreStandard Deviation 15.22

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026